Insight
NYSBA Releases Report on Advancing Diversity
1.5 hour read | September.26.2023
The New York State Bar Association released a report based on its task force's findings regarding advancing diversity.
Search Results
Insight
OLNS#11 – Bridging the Pond – U.S. Venture Capital Deals from a German Market Perspective
3 hour read | August.08.2023
Venture financings and deal terms in the U.S. and in Germany have many similarities but there are also some differences. To help navigate these ...
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2023
20 minute read | July.25.2023
Venture Funding and Tech Trends in AI in Drug Discovery
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2023
26 minute read | April.25.2023
This edition of Orrick’s life sciences publication series reviews key trends of venture investment in the life sciences industry during Q1 2023.
Insight
Deal Flow 3.0: 5 Things We Learned About European Tech Deal Terms in 2022
2 minute read | March.07.2023
Despite a shift to economic headwinds, investors injected more than $95 billion into the European tech market in 2022, the second-largest amount ever.
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2023
16 minute read | February.14.2023
Venture Funding and Tech Trends in Mental Health
Insight
OLNS#3 – Employment Law for Tech Companies (relaunched edition)
January.31.2023
OLNS#3 has all the Employment Law must-haves for young technology companies in Germany and key issues for startups to watch out for in the U.S., too!
Insight
Orrick Global Offshore Wind Report
by Minako Wakabayashi, Evan Stergoulis, Paul Zarnowiecki, Adam Smith and Oliver Sikora
December.12.2022
Powering Forward: Offshore Wind Growth Signals Things to Come
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2022
23 minute read | October.24.2022
Leveraging Non-Dilutive Financing For Drug Development and Favorably Licensing Developed Products as a Global Health Model
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2022
23 minute read | July.27.2022
Evolving Antitrust Scrutiny of Life Sciences M&A—What's in the Pipeline?
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2022
April.26.2022
A Conversation on Leveraging Spinouts to Preserve and Create Value During Financing Rounds, M&A and IPO Planning
Insight
Deal Flow 2.0: European Venture Capital Deal Term Review 2021
2 minute read | February.23.2022
Investors poured more than $100B into European tech last year, a staggering sum more than triple the size of investments made the previous year.